Literature DB >> 32286113

Analysis of Foveal Microvascular Abnormalities in Patients with Systemic Lupus Erythematosus Using Optical Coherence Tomography Angiography.

Qi An1, Jian Gao1, Lun Liu1, Rongfeng Liao1, Zongwen Shuai2.   

Abstract

Purpose: To analyze the abnormalities of foveal microvasculature in patients with systemic lupus erythematosus (SLE).
Methods: A cross-sectional study of 41 eyes of patients diagnosed with SLE and 40 eyes of healthy controls. Sections measuring 6 mm×6 mm centered on the fovea were obtained using optical coherence tomography angiography (OCTA).
Results: The area and perimeter of foveal avascular zone (FAZ) in SLE patients were greater than those in controls (both p < .05). The parafoveal vessel densities in the deep capillary plexus (DCP) of SLE patients were significantly decreased than those in controls (p < .001). There was a negative correlation between SLE disease activity index and parafoveal vessel density in DCP (p < .05).
Conclusion: Enlargement of the FAZ and decline of the parafoveal vessel density of DCP were revealed by OCTA in patients with SLE. Moreover, a negative correlation between parafoveal vessel density in DCP and disease activity index was detected in SLE patients.

Entities:  

Keywords:  Systemic lupus erythematosus; foveal microvasculature; optical coherence tomography angiography

Mesh:

Year:  2020        PMID: 32286113     DOI: 10.1080/09273948.2020.1735452

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Evaluation of retinal microvascular structures by optical coherence tomography angiography in primary Sjögren's syndrome.

Authors:  Neslihan Parmak Yener; Koray Ayar
Journal:  Int Ophthalmol       Date:  2021-11-08       Impact factor: 2.031

2.  Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.

Authors:  Sevgi Subasi; Kubra Demirci Kucuk; Senar San; Ayse Cefle; Ecem Onder Tokuc; Sibel Balci; Ayten Yazici
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-06       Impact factor: 3.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.